Abstract: A light duty, liquid cleaning composition comprising: at least two different surfactants, lauryol ethylene diamine triacetate, a zinc inorganic salt, and water.

Abstract: Selective MMP-13 inhibitors are pyridine derivatives of the formula or a pharmaceutically acceptable salt thereof, wherein: R1 and R2 independently are hydrogen, halo, hydroxy, C1–C6 alkyl, C1–C6 alkoxy, C2–C6 alkenyl, C2–C6 alkynyl, NO2, NR4R5, CN, or CF3; E is independently O or S; A and B independently are OR4 or NR4R5; R4 and R5 independently are H, C1–C6 alkyl, C2–C6 alkenyl, C2–C6 alkynyl, (CH2)n aryl, (CH2)n cycloalkyl, (CH2)n heteroaryl, or R4 and R5 when taken together with the nitrogen to which they are attached complete a 3- to 8-membered ring containing carbon atoms and optionally containing a heteroatom selected from O, S, or NH, and optionally substituted or unsubstituted; n is an integer of from 0 to 6.

Abstract: A plurality of electronic documents can be configured such that one or more of the electronic documents are subject to a user-designated restriction. The plurality of electronic documents can then be selected, in response to a user input, as an attachment to an electronic message. Thereafter, the plurality of electronic documents can be automatically and electronically transmitted as an attachment to the electronic message without one or more of the electronic documents that were subject to the user user-designated restriction. In this manner a user can select an entire file and then select electronic mail features in which document permissions are established such that electronic documents which should not be accessible cannot be retrieved, but electronic mail operations can proceed in sending those documents among the group or plurality of electronic documents, which are designed as accessible.

Abstract: Selective MMP-13 inhibitors are isophthalic acid derivatives of the formula wherein: R1, R2, and R3 independently are hydrogen, halo, hydroxy, C1–C6 alkyl, C1–C6 alkoxy, C2–C6 alkenyl, C2–C6 alkynyl, NO2, NR4R5, CN, or CF3; E is independently O or S; A and B independently are OR4 or NR4R5; each R4 and R5 independently are H, C1–C6 alkyl, C2–C6 alkenyl, C2–C6 alkynyl, (CH2)n aryl, (CH2)n cycloalkyl, (CH2)n heteroaryl, or R4 and R5 when taken together with the nitrogen to which they are attached complete a 3- to 8-membered ring, optionally containing a heteroatom selected from O, S, or NH, and optionally substituted or unsubstituted; n is 0 to 6; or a pharmaceutically acceptable salt thereof. The compounds are useful for treating diseases in a mammal that are mediated by MMP enzymes.

Abstract: A multi-display computer system comprises a display member rotatably coupled to a base member. The display member has a first display device disposed on an interior surface thereof and a second display device disposed on an exterior surface thereof. The computer system also comprises a display manager executable by a processor and adapted to enable a user to automatically control a display mode of the second display device independent of a display mode of the first display device.

Abstract: Disclosed is a system including a circuit board and several pluggable modules coupled to the circuit board. The several pluggable modules are insertable through side-by-side slots in an enclosure in which the circuit board resides. A first pluggable module is coupled to the circuit board via a first connector, while a second pluggable module is coupled to the circuit board via a second connector such that the second pluggable module is laterally offset from the first pluggable module. The first and second connectors are right angle connectors, and the second right angle connector is inverted relative to the first right angle connector. The first and second pluggable modules are I/O modules for transporting high speed differential signals, and wherein the first pluggable module includes several XFP connectors, and wherein the second pluggable module includes several SFP connectors. The second pluggable module includes several SFP connectors arranged on both sides of the pluggable module.

Abstract: Selective MMP-13 inhibitors are pyridine derivatives of the formula or a pharmaceutically acceptable salt thereof, wherein: R1 and R2 independently are hydrogen, halo, hydroxy, C1-C6 alkyl, C1-C6 alkoxy, C2-C6 alkenyl, C2-C6 alkynyl, NO2, NR4R5, CN, or CF3, E is independently O or S; A and B independently are OR4 or NR4R5; R4 and R5 independently are H, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, (CH2)n aryl, (CH2)n cycloalkyl, (CH2)n heteroaryl, or R4 and R5 when taken together with the nitrogen to which they are attached complete a 3- to 8-membered ring containing carbon atoms and optionally containing a heteroatom selected from O, S, or NH, and optionally substituted or unsubstituted, n is an integer of from 0 to 6.

Abstract: An imaging system comprises a client device with a display unit, a server controller, stored document information, document modification methods, an imaging device, and documents to be imaged. A user of the client device requests a particular stored document to be displayed on the display unit. The server receives the client request and creates a first user interface for the user to view the stored document and to either accept or request modification to the displayed document. If the user requests modification to the displayed document, the server creates a second user interface for the user to communicate to the imaging system a desired modification to be made in the displayed document. The server determines the best means to address the request, modifies the document, and stores the document information for subsequent use.

Abstract: Disclosed are systems and methods for de-skewing media when using an automatic media feeder comprising a registration guide and a registration tab disposed to cooperate with the registration guide in providing de-skewing of media when an edge of the media passes over the registration tab and is deflected thereby toward the registration guide.

Abstract: This invention provides indole and benzimidazole 15-lipoxygenase (15-LO) inhibitors of the formula where one of Y1 and Y2 is CH, N, or NH, and the other is R3 includes H, halo, HN2, COOH, alkyl; R4 includes halo, alkyl, and alkoxy; Z is C, CH, or NR5; R5 is H or oxycabonyl; and each X is independently H, alkyl, alkoxy, or halo.

Abstract: Embodiments permit privileged administrators of computer networks to configure authentication policies. One or more authentication policies can be associated with a computer network. A customer administrator or other privileged person can be permitted to configure one or more of the authentication policies according to particular preferences of the customer administrator or privileged person. The methods and systems can provide enablement/disablement configuration capabilities that can allow a customer administrator or other privileged administrator to select and configure appropriate authentication policies in the context of accessing a computer network.

Abstract: Selective MMP-13 inhibitors are pyridine derivatives of the formula 1

Abstract: A light duty, liquid cleaning composition comprising: at least two different surfactants, lauryol ethylene diamine triacetate, a zinc inorganic salt, and water.

Abstract: This invention provides indole and benzimidazole 15-lipoxygenase (15-LO) inhibitors of the formula where one of Y1 and Y2 is CH, N, or NH, and the other is R3 includes H, halo. HN2, COOH, alkyl; R4 includes halo, alkyl, and alkoxy; Z is C, CH, or NR5; R5 is H or oxycabonyl; and each X is independently H, alkyl, alkoxy, or halo.

Abstract: A light duty, liquid comprising of at least two different surfactants, lauryol ethylenediaminetriacetate, a zinc inorganic salt and water.

Abstract: Quinoxaline compounds are described as well as methods for the preparation and pharmaceutical compositions of same, which are useful as interleukin-8 (IL-8) receptor antagonists and can be used in the treatment of a chemokine-mediated disease wherein the chemokine binds to an IL-8a (CXCR1) or b (CXCR2) receptor such as a chemokine-mediated disease selected from psoriasis, or atopic distress syndrome, arthritis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, gastric ulcer, septic shock, endotoxic shock, gram-negative sepsis, toxic shock syndrome, stroke, cardiac and renal reperfusion injury, glomerulo-nephritis, or thrombosis, Alzheimer's disease, graft versus host reaction, allograft rejections, or allergic diseases.

Abstract: The present invention relates to novel compounds and medical methods of treatment of inflammation, atherosclerosis, restenosis, and immune disorders especially those associated with lymphocyte or monocyte accumulation such as arthritis and transplant rejection. More particularly, the present invention concerns the use of 2-phenyl benzimidazole derivatives.

Abstract: The present invention provides compounds of Formula I shown below. The present invention also provides methods of treating or preventing 3 inflammation or atherosclerosis, and a pharmaceutical composition that contains a compound of Formula I.

Abstract: A light duty, liquid cleaning composition comprising: a C8-C18 ethoxylated alkyl ether sulfate surfactant, a magnesium salt of a C8-C18 linear alkyl benzene sulfonate, a sodium salt of a C8-C18 linear alkyl benzene sulfonate, an amine oxide, a polyalkylglucoside, a zinc inorganic salt, and water.

Abstract: A light duty, liquid comprising: a paraffin sulfonate, an alpha olefin sulfonate, an amine oxide, lauryol ethylenediaminetriacetate, a zinc inorganic salt and water.